X-ray Device Makers In Japan Excluded From Bidding Due To Collusion
This article was originally published in PharmAsia News
Executive Summary
Japan Fair Trade Commission finds that three X-ray device manufacturers have repeatedly been involved in collusive bidding for orders from public hospitals. JFTC has excluded two companies, Tokyo-based Toshiba Medical Systems and Kyodo-based Shimadzu Corporation, from future bidding for violating the anti-trust law. The commission also ordered fined Toshiba Medical Systems and Shimadzu ¥10 million and ¥6.2 million, respectively. The third company, Tokyo-based Hitachi Medical Corp. was not fined and also not excluded from future bidding because it reported the collusive bidding practice to authorities.The three companies account for 70 percent of the X-ray device market in Japan. (Click here for more - Japanese language
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.